NBS-C BioScience & Consulting

Executive Summary

NBS-C BioScience & Consulting is a privately held contract research organization (CRO) based in Vienna, Austria, founded in 2008. The company specializes in molecular interaction analysis using Surface Plasmon Resonance (SPR) technology, primarily via Biacore™ systems, serving clients in biological drug development from research through clinical stages. Additionally, NBS-C manufactures reagents for allergy research and diagnostics, positioning itself as a niche provider in the allergy diagnostics supply chain. As a small but specialized CRO, the company benefits from the growing demand for biologics characterization and quality control, particularly in the European market. Its focus on SPR-based services aligns with industry trends toward label-free, real-time binding analysis for drug development and biosimilar comparability studies. The company operates as a consulting and analytical service provider, generating revenue through fee-for-service projects and reagent sales. With no disclosed funding or valuation, NBS-C remains a bootstrapped operation, likely serving a steady client base in academia and biopharma.

Upcoming Catalysts (preview)

• Q3 2026New ISO 17025 accreditation for SPR analytical methods, enhancing credibility for regulated biopharma projects65% success
• TBDStrategic partnership with a major European biopharma company for biosimilar characterization services40% success
• Q2 2026Launch of a new high-throughput SPR screening service for early-stage drug discovery55% success